186 related articles for article (PubMed ID: 29966864)
21. Diverse effects of phospholipase A2 receptor expression on LNCaP and PC-3 prostate cancer cell growth
Friedemann M; Nacke B; Hagelgans A; Jandeck C; Bechmann N; Ullrich M; Belter B; Neuber C; Sukocheva O; Pietzsch J; Menschikowski M
Oncotarget; 2018 Nov; 9(89):35983-35996. PubMed ID: 30542512
[TBL] [Abstract][Full Text] [Related]
22. Expression of serotonin receptors and role of serotonin in human prostate cancer tissue and cell lines.
Dizeyi N; Bjartell A; Nilsson E; Hansson J; Gadaleanu V; Cross N; Abrahamsson PA
Prostate; 2004 May; 59(3):328-36. PubMed ID: 15042609
[TBL] [Abstract][Full Text] [Related]
23. Pure human butyrylcholinesterase hydrolyzes octanoyl ghrelin to desacyl ghrelin.
Schopfer LM; Lockridge O; Brimijoin S
Gen Comp Endocrinol; 2015 Dec; 224():61-8. PubMed ID: 26073531
[TBL] [Abstract][Full Text] [Related]
24. Aurora B expression directly correlates with prostate cancer malignancy and influence prostate cell proliferation.
Chieffi P; Cozzolino L; Kisslinger A; Libertini S; Staibano S; Mansueto G; De Rosa G; Villacci A; Vitale M; Linardopoulos S; Portella G; Tramontano D
Prostate; 2006 Feb; 66(3):326-33. PubMed ID: 16267859
[TBL] [Abstract][Full Text] [Related]
25. Expression of receptor protein tyrosine phosphatase alpha mRNA in human prostate cancer cell lines.
Zelivianski S; Dean J; Madhavan D; Lin FF; Lin MF
Mol Cell Biochem; 2000 May; 208(1-2):11-8. PubMed ID: 10939623
[TBL] [Abstract][Full Text] [Related]
26. Isolation and enrichment of PC-3 prostate cancer stem-like cells using MACS and serum-free medium.
Sheng X; Li Z; Wang DL; Li WB; Luo Z; Chen KH; Cao JJ; Yu C; Liu WJ
Oncol Lett; 2013 Mar; 5(3):787-792. PubMed ID: 23426586
[TBL] [Abstract][Full Text] [Related]
27. Down-regulation of neu/HER-2 by interferon-gamma in prostate cancer cells.
Kominsky SL; Hobeika AC; Lake FA; Torres BA; Johnson HM
Cancer Res; 2000 Jul; 60(14):3904-8. PubMed ID: 10919667
[TBL] [Abstract][Full Text] [Related]
28. Involvement of prostate specific antigen in the stimulation of LNCaP cell growth.
Wang L; Liu X; Kreis W; Budman D
Oncol Rep; 1996 Sep; 3(5):911-7. PubMed ID: 21594481
[TBL] [Abstract][Full Text] [Related]
29. Decreased Activity of Circulating Butyrylcholinesterase in Blood Is an Independent Prognostic Marker in Pancreatic Cancer Patients.
Klocker EV; Barth DA; Riedl JM; Prinz F; Szkandera J; Schlick K; Kornprat P; Lackner K; Lindenmann J; Stöger H; Stotz M; Gerger A; Pichler M
Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32375339
[No Abstract] [Full Text] [Related]
30. Downregulation of androgen receptor expression by luteolin causes inhibition of cell proliferation and induction of apoptosis in human prostate cancer cells and xenografts.
Chiu FL; Lin JK
Prostate; 2008 Jan; 68(1):61-71. PubMed ID: 18008333
[TBL] [Abstract][Full Text] [Related]
31. Human prostate tumor angiogenesis in nude mice: metalloprotease and plasminogen activator activities during tumor growth and neovascularization of subcutaneously injected matrigel impregnated with human prostate tumor cells.
Wilson MJ; Sinha AA
Anat Rec; 1997 Sep; 249(1):63-73. PubMed ID: 9294650
[TBL] [Abstract][Full Text] [Related]
32. Growth of human prostate cancer cells is significantly suppressed in vitro with sodium butyrate through apoptosis.
Qiu J; Gao Z; Shima H
Oncol Rep; 2012 Jan; 27(1):160-7. PubMed ID: 21947091
[TBL] [Abstract][Full Text] [Related]
33. Enrichment of prostate cancer stem-like cells from human prostate cancer cell lines by culture in serum-free medium and chemoradiotherapy.
Wang L; Huang X; Zheng X; Wang X; Li S; Zhang L; Yang Z; Xia Z
Int J Biol Sci; 2013; 9(5):472-9. PubMed ID: 23781140
[TBL] [Abstract][Full Text] [Related]
34. Butyrylcholinesterase regulates central ghrelin signaling and has an impact on food intake and glucose homeostasis.
Chen VP; Gao Y; Geng L; Brimijoin S
Int J Obes (Lond); 2017 Sep; 41(9):1413-1419. PubMed ID: 28529331
[TBL] [Abstract][Full Text] [Related]
35. Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells.
Weiss-Messer E; Merom O; Adi A; Karry R; Bidosee M; Ber R; Kaploun A; Stein A; Barkey RJ
Mol Cell Endocrinol; 2004 May; 220(1-2):109-23. PubMed ID: 15196705
[TBL] [Abstract][Full Text] [Related]
36. Insulin-like growth factor (IGF) system components in human prostatic cancer cell-lines: LNCaP, DU145, and PC-3 cells.
Kimura G; Kasuya J; Giannini S; Honda Y; Mohan S; Kawachi M; Akimoto M; Fujita-Yamaguchi Y
Int J Urol; 1996 Jan; 3(1):39-46. PubMed ID: 8646598
[TBL] [Abstract][Full Text] [Related]
37. RNA interference targeting PSCA suppresses primary tumor growth and metastasis formation of human prostate cancer xenografts in SCID mice.
Zhao Z; He J; Kang R; Zhao S; Liu L; Li F
Prostate; 2016 Feb; 76(2):184-98. PubMed ID: 26477693
[TBL] [Abstract][Full Text] [Related]
38. Extended survivability of prostate cancer cells in the absence of trophic factors: increased proliferation, evasion of apoptosis, and the role of apoptosis proteins.
Tang DG; Li L; Chopra DP; Porter AT
Cancer Res; 1998 Aug; 58(15):3466-79. PubMed ID: 9699682
[TBL] [Abstract][Full Text] [Related]
39. Expression of adrenomedullin and peptide amidation activity in human prostate cancer and in human prostate cancer cell lines.
Rocchi P; Boudouresque F; Zamora AJ; Muracciole X; Lechevallier E; Martin PM; Ouafik L
Cancer Res; 2001 Feb; 61(3):1196-206. PubMed ID: 11221851
[TBL] [Abstract][Full Text] [Related]
40. GLI1 confers profound phenotypic changes upon LNCaP prostate cancer cells that include the acquisition of a hormone independent state.
Nadendla SK; Hazan A; Ward M; Harper LJ; Moutasim K; Bianchi LS; Naase M; Ghali L; Thomas GJ; Prowse DM; Philpott MP; Neill GW
PLoS One; 2011; 6(5):e20271. PubMed ID: 21633508
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
